Corrigendum to "Clinical and economic impact of the availability of innovative therapies for advanced lung cancer in men in Latin America: a population-based secondary data study"- the Lancet Regional Health-Americas 2025; Volume 49: 101172; DOI: 10.1016/j.lana.2025.101172.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 41323148.
- Also identified by DOI 10.1016/j.lana.2025.101300 and PMC identifier 12664093.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
[This corrects the article DOI: 10.1016/j.lana.2025.101172.].